Danaher Co. to Issue Quarterly Dividend of $0.27 (NYSE:DHR)

Danaher Co. (NYSE:DHR) announced a quarterly dividend on Tuesday, December 10th,RTT News reports. Stockholders of record on Friday, December 27th will be paid a dividend of 0.27 per share by the conglomerate on Friday, January 31st. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date is Friday, December 27th.

Danaher has raised its dividend by an average of 13.4% annually over the last three years. Danaher has a dividend payout ratio of 12.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Danaher to earn $8.38 per share next year, which means the company should continue to be able to cover its $1.08 annual dividend with an expected future payout ratio of 12.9%.

Danaher Stock Up 0.7 %

Shares of NYSE:DHR opened at $230.75 on Wednesday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a market cap of $166.66 billion, a price-to-earnings ratio of 44.04, a PEG ratio of 4.33 and a beta of 0.83. The stock’s 50-day moving average price is $241.38 and its two-hundred day moving average price is $255.86. Danaher has a 12-month low of $222.53 and a 12-month high of $281.70.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same period last year, the company earned $2.02 earnings per share. The company’s quarterly revenue was up 3.1% on a year-over-year basis. On average, research analysts forecast that Danaher will post 7.5 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on DHR. Guggenheim began coverage on Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. KeyCorp lifted their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Evercore ISI increased their target price on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Robert W. Baird reduced their price target on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Finally, Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a research note on Thursday, October 31st. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $287.05.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.